On ECHEMI
Home > Drugs > Jiangsu Nhwa Pharmaceutical Co., Ltd.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

  • Founded in:

    1999-03-29
  • Country:

    China China
  • Address:

    No. 18, Yangshan Road, Xuzhou Economic and Technological Development Zone
  • Tax NO.:

    913203001363846728
  • Registered Funds:

    1016.176792 million yuan
  • Website:

  • Email:

Related Drugs
Flumazenil Injection
Active ingredient: Flumazenil; Excipients: Disodium ethylenediaminetetraacetate, acetic acid, sodium chloride, water for injection. The chemical name of Flumazenil is 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo-[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester.
Name Description Content CAS NO. Registered Holders
Flumazenil

Flumazenil is a benzodiazepine receptor antagonist that competitively inhibits the reaction of benzodiazepines with their receptors, thereby specifically blocking their central nervous system effects.

More

Flumazenil is a benzodiazepine receptor antagonist that competitively inhibits the reaction of benzodiazepines with their receptors, thereby specifically blocking their central nervous system effects.

78755-81-4 21
Children's compound sulfamethoxazole tablets
This product is a compound preparation, each tablet contains the active ingredients 0.4g of sulfamethoxazole and 0.08g of trimethoprim.
Name Description Content CAS NO. Registered Holders
Sulfamethoxazole

After oral administration, it is completely absorbed from the gastrointestinal tract and can reach a steady-state blood concentration. It can be widely distributed in tissues and body fluids throughout the body, can penetrate the blood-cerebrospinal fluid barrier to reach therapeutic concentrations, and can also cross the blood-placental barrier and be secreted into breast milk.

More

After oral administration, it is completely absorbed from the gastrointestinal tract and can reach a steady-state blood concentration. It can be widely distributed in tissues and body fluids throughout the body, can penetrate the blood-cerebrospinal fluid barrier to reach therapeutic concentrations, and can also cross the blood-placental barrier and be secreted into breast milk.

0.4g 723-46-6 33
Trimethoprim

After oral administration, it is completely absorbed from the gastrointestinal tract and can reach a steady-state blood concentration. It can be widely distributed in tissues and body fluids throughout the body, can penetrate the blood-cerebrospinal fluid barrier to reach therapeutic concentrations, and can also cross the blood-placental barrier and be secreted into breast milk.

More

After oral administration, it is completely absorbed from the gastrointestinal tract and can reach a steady-state blood concentration. It can be widely distributed in tissues and body fluids throughout the body, can penetrate the blood-cerebrospinal fluid barrier to reach therapeutic concentrations, and can also cross the blood-placental barrier and be secreted into breast milk.

0.08g 738-70-5 44
Citalopram Hydrobromide Tablets
Citalopram hydrobromide, chemical name 1,3-dihydro-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile hydrobromide
Name Description Content CAS NO. Registered Holders
Citalopram hydrobromide

Citalopram is an antidepressant and a highly selective 5-HT reuptake inhibitor. Its antidepressant mechanism may be related to inhibiting the reuptake of 5-HT by central nervous system neurons, thereby enhancing the function of central serotonergic nerves. It has little effect on the reuptake of norepinephrine and dopamine, and its effect of inhibiting 5-HT reuptake is mainly exerted by its (S)-enantiomer.

More

Citalopram is an antidepressant and a highly selective 5-HT reuptake inhibitor. Its antidepressant mechanism may be related to inhibiting the reuptake of 5-HT by central nervous system neurons, thereby enhancing the function of central serotonergic nerves. It has little effect on the reuptake of norepinephrine and dopamine, and its effect of inhibiting 5-HT reuptake is mainly exerted by its (S)-enantiomer.

59729-32-7 43
Nefopam Hydrochloride Tablets
The main component of this product and its chemical name is: 5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-oxazolidinone hydrochloride. Its structural formula is: Molecular formula: C17H19NO·HCl Molecular weight: 289.80
Name Description Content CAS NO. Registered Holders
Nefopam hydrochloride

This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.

More

This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.

23327-57-3 12
Fenofibrate Capsules (Ⅱ)
Name Description Content CAS NO. Registered Holders
Fenofibrate

No specific description of pharmacological action is clear from the above information

More

No specific description of pharmacological action is clear from the above information

49562-28-9 63
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.